BiotechTube
Home/iTolerance/Anthony Japour
AJ

Anthony Japour

Chief Executive Officer

iTolerance

Therapeutic Areas

Type 1 DiabetesLiver Diseases

iTolerance Pipeline

DrugIndicationPhase
iTOL-101Type 1 DiabetesPreclinical
iTOL-102Type 1 DiabetesPreclinical
iTOL-201Liver DiseasesPreclinical
iTOL-401Not SpecifiedPreclinical